Mayer Brown and the Seton Hall Law School Center for Health & Pharmaceutical Law presented Hot Topics in Life Sciences Law, a symposium tailored to legal professionals and executives at the forefront of the biotech, pharmaceutical, and medical device industries.

The symposium explored emerging issues and legal trends impacting the life sciences industries, including:

  • M&A trends and antitrust developments affecting dealmaking
  • The Inflation Reduction Act: recent litigations and implications for innovation
  • Technology and Pharma, from AI to Privacy: What are the key considerations for in-house counsel
  • Lifecycle management for FDA-regulated products: navigating the intersection of FDA’s regulatory exclusivity regimes and patent protection
  • Intellectual property developments shaping product lifecycles


Charlie Adams, Managing Director, Global Head of Life Science Tools and Diagnostics, Citi

William Coppola, Distinguished Practitioner in Residence at the Gibbons Institute of Law, Science & Technology, Seton Hall Law

Jeffrey Lee, VP and Head of IP, Sail Biomedicines

Sharick Naqi, Director and Senior Counsel IP Lead, Novartis Gene Therapies

David Opderbeck, Professor of Law and Co-Director of the Gibbons Institute of Law, Science & Technology, Seton Hall

Andrew J. Parker, Senior Vice President - Head of Global Business Development, bioMérieux Inc.

Kenneth Peist, VP, Intellectual Property, Dermavant Sciences, Inc.

Peter J. Pitts, President, Center for Medicine in the Public Interest, Visiting Professor, University of Paris School of Medicine

Brian Robinson, Head IP—Cardiovascular, Novartis

Brian Stone, Associate General Counsel, Global Legal-Regulatory, Viatris Inc.


View Program Agenda


Other Event Documents

Servicios e Industrias Relacionadas

Stay Up To Date With Our Insights

See how we use a multidisciplinary, integrated approach to meet our clients' needs.